Innoviva, Inc. (THRX)
Feb 14, 2024 - THRX was delisted (reason: acquired by Concentra Biosciences)
4.060
0.00 (0.00%)
Inactive · Last trade price
on Feb 13, 2024
Theseus Pharmaceuticals Employees
Innoviva had 127 employees as of December 31, 2024. The number of employees increased by 15 or 13.39% compared to the previous year.
Employees
127
Change (1Y)
15
Growth (1Y)
13.39%
Revenue / Employee
$2,824,496
Profits / Employee
$184,189
Market Cap
1.14B
Employees Chart
THRX News
- 1 year ago - Theseus Pharmaceuticals Announces Closing of Tender Offer - PRNewsWire
- 1 year ago - Concentra Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Theseus Pharmaceuticals - Business Wire
- 1 year ago - THESEUS PHARMACEUTICALS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Theseus Pharmaceuticals, Inc. - THRX - PRNewsWire
- 1 year ago - THESEUS PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Theseus Pharmaceuticals, Inc. - THRX - Business Wire
- 1 year ago - Theseus Pharmaceuticals Enters into Agreement to Be Acquired by Concentra Biosciences for between $3.90 and $4.05 in Cash per Share Plus a Contingent Value Right - PRNewsWire
- 1 year ago - Theseus Pharmaceuticals Confirms Receipt of Unsolicited Expression of Interest from Foresite Capital, LLC and OrbiMed Advisors LLC and Unsolicited Proposal from Concentra Biosciences LLC - PRNewsWire
- 1 year ago - Theseus Pharmaceuticals Announces Process to Explore Strategic Alternatives - PRNewsWire
- 1 year ago - Theseus Pharmaceuticals to Participate in the Stifel 2023 Healthcare Conference - PRNewsWire